Open Journal of Blood Diseases
Vol.2 No.3(2012), Paper ID 22224, 7
pages
DOI:10.4236/ojbd.2012.23012
Darbepoietin-Alfa after High-Dose Melphalan and Autologous Hemopoietic Progenitor Cell in Multiple Myeloma Patients: A Pilot Study
Massimo Martino, Ida Callea, Tiziana Moscato, Antonella Pontari, Elisa Spiniello, Roberta Fedele
Department of Oncology and Hematology, Azienda Ospedaliera BMM, Reggio Calabria, Italy
Department of Oncology and Hematology, Azienda Ospedaliera BMM, Reggio Calabria, Italy
Department of Oncology and Hematology, Azienda Ospedaliera BMM, Reggio Calabria, Italy
Department of Oncology and Hematology, Azienda Ospedaliera BMM, Reggio Calabria, Italy
Department of Oncology and Hematology, Azienda Ospedaliera BMM, Reggio Calabria, Italy
Department of Oncology and Hematology, Azienda Ospedaliera BMM, Reggio Calabria, Italy
Copyright © 2012 Massimo Martino, Ida Callea, Tiziana Moscato, Antonella Pontari, Elisa Spiniello, Roberta Fedele et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Martino, M. , Callea, I. , Moscato, T. , Pontari, A. , Spiniello, E. and Fedele, R. (2012) Darbepoietin-Alfa after High-Dose Melphalan and Autologous Hemopoietic Progenitor Cell in Multiple Myeloma Patients: A Pilot Study.
Open Journal of Blood Diseases,
2, 59-65. doi:
10.4236/ojbd.2012.23012.